secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lineage Cell Therapeutics, Inc. (LCTX)
CIK:        0000876343
Form:       8-K
Filed at:   2022-10-28T23:59:59+00:00
Accession:  0001493152-22-029887
Event type: litigation
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02
LLM model:  deepseek-v4-flash:cloud@v2

Lineage Cell Therapeutics settles Asterias merger lawsuit for $10.65M
---------------------------------------------------------------------

- Settlement of $10.65M funded ~$7.12M by insurers and ~$3.53M by Lineage (cash or shares).
- Lineage may issue unregistered common shares under Section 3(a)(10) for its portion.
- Settlement subject to Delaware Chancery Court approval; denial would mean continued defense.
- Defendants, including Lineage, deny all claims and no admission of liability.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/876343/000149315222029887/0001493152-22-029887-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/876343/000149315222029887/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-029887

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer